Abstract:Each time the virus starts a new round of expression/replication, even under effective antiretroviral therapy (ART), the transactivator of viral transcription Tat is one of the first HIV-1 protein to be produced, as it is strictly required for HIV replication and spreading. At this stage, most of the Tat protein exits infected cells, accumulates in the extracellular matrix and exerts profound effects on both the virus and neighbor cells, mostly of the innate and adaptive immune systems. Through these effects, extracellular Tat contributes to the acquisition of infection, spreading and progression to AIDS in untreated patients, or to non-AIDS co-morbidities in ART-treated individuals, who experience inflammation and immune activation despite virus suppression. Here, we review the role of extracellular Tat in both the virus life cycle and on cells of the innate and adaptive immune system, and we provide epidemiological and experimental evidence of the importance of targeting Tat to block residual HIV expression and replication. Finally, we briefly review vaccine studies showing that a therapeutic Tat vaccine intensifies ART, while its inclusion in a preventative vaccine may blunt escape from neutralizing antibodies and block early events in HIV acquisition.

What problem does this paper attempt to address?

The paper attempts to address the role of HIV-1 Tat protein in HIV infection and pathogenesis, particularly the impact of Tat protein's interaction with host receptors. Specifically, the paper focuses on the following aspects: 1. **Functions of HIV-1 Tat Protein**: - Tat protein is a crucial protein necessary for HIV-1 replication and dissemination, primarily functioning by promoting viral gene expression and transcription. - During acute infection, approximately two-thirds of Tat protein is released extracellularly, exerting profound effects on the virus and various cell types. 2. **Role of Extracellular Tat Protein (eTat)**: - eTat participates in viral acquisition, dissemination, and disease progression through interactions with host receptors. - In patients receiving antiretroviral therapy (ART), eTat persists despite suppressed viral replication and may lead to chronic inflammation and immune activation, resulting in non-AIDS-related complications. 3. **Specific Mechanisms of Tat Protein in HIV Infection and Pathology**: - The paper details the structure and functional domains of Tat protein and how these features enable it to interact with various molecules. - Special attention is given to the interaction between Tat protein and RGD-binding integrins, which are highly expressed in endothelial cells and dendritic cells, and are involved in HIV-related endothelial dysfunction and the pathogenesis of Kaposi's sarcoma. 4. **Vaccine Strategies Targeting Tat Protein**: - The paper emphasizes the importance of targeting Tat protein as a prophylactic and therapeutic vaccine target to block residual HIV expression and replication. - Therapeutic Tat vaccines could enhance the efficacy of ART, while prophylactic vaccines might help prevent neutralizing antibody escape and block early HIV infection events. In summary, the paper aims to comprehensively explore the role of HIV-1 Tat protein in the viral lifecycle and host cells, particularly in its extracellular form, and how targeting Tat protein could improve strategies for the treatment and prevention of HIV infection.

Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis